The general practitioner-drug representative interaction: an ethical perspective
While the debate regarding the pharmaceutical representative-practitioner relationship is often an emotive one, it is clear that practitioners need the pharmaceutical industry to deliver new and better treatments. The doctor must acknowledge the potential of being subtly influenced by interaction with drug representatives and embrace ways to counterbalance it. Application of a simple ‘1:1 minute rule’ is one possible method to counteract potential for bias and enhance the relationship between the drug representative and the prescriber to the benefit of the patient.
CommentsThe original article is available at http://www.rcsismj.com/ Part of the RCSsmj collection: https://doi.org/10.25419/rcsi.c.6767511.v1
Published CitationRourke M. The general practitioner-drug representative interaction: an ethical perspective. RCSIsmj. 2012;5(1):93-95
- Undergraduate Research
PublisherRCSI University of Medicine and Health Sciences
- Published Version (Version of Record)